Ching Y. Wang

2.3k total citations
64 papers, 1.8k citations indexed

About

Ching Y. Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ching Y. Wang has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ching Y. Wang's work include Carcinogens and Genotoxicity Assessment (15 papers), Immunotherapy and Immune Responses (12 papers) and Prostate Cancer Treatment and Research (12 papers). Ching Y. Wang is often cited by papers focused on Carcinogens and Genotoxicity Assessment (15 papers), Immunotherapy and Immune Responses (12 papers) and Prostate Cancer Treatment and Research (12 papers). Ching Y. Wang collaborates with scholars based in United States, Japan and France. Ching Y. Wang's co-authors include Gabriel P. Haas, Charles M. King, Mei‐Sie Lee, Gustavo de la Roza, Nicolas Barry Delongchamps, Yoshihisa Kinoshita, Otis W. Brawley, Katsumi Imaida, Steve Landas and Katsuyuki Kuratsukuri and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and The Journal of Urology.

In The Last Decade

Ching Y. Wang

62 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching Y. Wang United States 23 617 545 423 335 222 64 1.8k
Yao Shen United States 25 1.2k 1.9× 413 0.8× 550 1.3× 439 1.3× 156 0.7× 69 3.0k
Andrew G. Stead United States 21 414 0.7× 501 0.9× 354 0.8× 954 2.8× 275 1.2× 54 2.0k
K. Sree Kumar United States 30 673 1.1× 293 0.5× 244 0.6× 211 0.6× 879 4.0× 58 2.1k
Andrea Manni United States 35 1.5k 2.5× 387 0.7× 678 1.6× 937 2.8× 90 0.4× 161 3.8k
Shugo Suzuki Japan 32 1.1k 1.8× 387 0.7× 467 1.1× 342 1.0× 51 0.2× 141 2.6k
Theodore L. McLemore United States 22 798 1.3× 578 1.1× 557 1.3× 466 1.4× 59 0.3× 52 2.3k
Chendil Damodaran United States 34 1.7k 2.8× 318 0.6× 520 1.2× 680 2.0× 118 0.5× 88 3.4k
Marshall W. Anderson United States 32 1.5k 2.4× 375 0.7× 1.0k 2.4× 697 2.1× 83 0.4× 95 2.6k
Phil R. Taylor United States 21 1.2k 2.0× 273 0.5× 490 1.2× 419 1.3× 66 0.3× 27 3.2k
Jinli Luo United Kingdom 22 996 1.6× 260 0.5× 490 1.2× 374 1.1× 80 0.4× 63 2.0k

Countries citing papers authored by Ching Y. Wang

Since Specialization
Citations

This map shows the geographic impact of Ching Y. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Y. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Y. Wang more than expected).

Fields of papers citing papers by Ching Y. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching Y. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Y. Wang. The network helps show where Ching Y. Wang may publish in the future.

Co-authorship network of co-authors of Ching Y. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching Y. Wang. A scholar is included among the top collaborators of Ching Y. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching Y. Wang. Ching Y. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iguchi, Taro, Ching Y. Wang, Nicolas Barry Delongchamps, et al.. (2015). Association of MnSOD AA Genotype with the Progression of Prostate Cancer. PLoS ONE. 10(7). e0131325–e0131325. 11 indexed citations
2.
Wang, Ching Y., et al.. (2006). Structural Model Reveals Key Interactions in the Assembly of the Pregnane X Receptor/Corepressor Complex. Molecular Pharmacology. 69(5). 1513–1517. 38 indexed citations
3.
Liu, Zhi‐Wei, et al.. (2006). Shape Signatures: speeding up computer aided drug discovery. Drug Discovery Today. 11(19-20). 895–904. 24 indexed citations
5.
Lambert, Joshua D., Dapeng Chen, Ching Y. Wang, et al.. (2005). Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies. Bioorganic & Medicinal Chemistry. 13(7). 2501–2507. 8 indexed citations
6.
Kuratsukuri, Katsuyuki, Tomomichi Sone, Ching Y. Wang, et al.. (2002). Inhibition of prostate‐specific membrane antigen (PSMA)‐positive tumor growth by vaccination with either full‐length or the C‐terminal end of PSMA. International Journal of Cancer. 102(3). 244–249. 12 indexed citations
7.
Nishisaka, Nobuyasu, et al.. (2001). Murine Animal Model. Methods in molecular medicine. 53. 255–264.
8.
Kuratsukuri, Katsuyuki, et al.. (2000). Clinical trials of immunotherapy for advanced prostate cancer. Urologic Oncology Seminars and Original Investigations. 5(6). 265–273. 13 indexed citations
10.
King, Charles M., et al.. (1997). Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 376(1-2). 123–128. 39 indexed citations
11.
Jones, Richard F., et al.. (1994). Mutation and altered expression of p53 genes in experimental rat bladder tumor cells. Molecular Carcinogenesis. 9(2). 95–104. 12 indexed citations
12.
Sone, Tomomichi, Kim Zukowski, Susan Land, et al.. (1994). Characteristics of a purified dog hepatic microsomal N, O-acyltransferase. Carcinogenesis. 15(4). 595–599. 6 indexed citations
13.
Wang, Ching Y., Kim Zukowski, Mei‐Sie Lee, & Tomomichi Sone. (1992). Purification and characterization of rat hepatic microsomal N,O-acyltransferases. Carcinogenesis. 13(11). 2017–2020. 5 indexed citations
14.
Choshi, Tominari, Ching Y. Wang, Hisamitsu Nagase, et al.. (1992). Synthesis of Dibenzoylmethane Derivaives and Inhibition of Mutagenicity in Salmonella typhimurium.. Chemical and Pharmaceutical Bulletin. 40(4). 1047–1049. 30 indexed citations
15.
Sone, Tomomichi, et al.. (1992). Purification and Characterization of Hamster Hepatic Microsomal N,O-Acetyltransferase.. Chemical and Pharmaceutical Bulletin. 40(10). 2857–2859. 6 indexed citations
16.
Imaida, Katsumi, Mei‐Sie Lee, Ching Y. Wang, & Charles M. King. (1991). Carcinogenicity of dinitropyrenes in the weanling female CD rat. Carcinogenesis. 12(7). 1187–1191. 27 indexed citations
17.
Wang, Ching Y., Mei‐Sie Lee, & Kim Zukowski. (1991). Inhibition by diacylmethane derivatives of mutagenicity in Salmonella typhimurium and tRNA-binding of chemical carcinogens. Mutation Research Letters. 262(3). 189–193. 6 indexed citations
18.
Dêbiec‐Rychter, Maria, Masayuki Azuma, Kim Zukowski, Ryoichi Oyasu, & Ching Y. Wang. (1991). Specific chromosome change associated with acquisition in vivo of tumorigenicity in carcinogen‐induced rat urinary bladder carcinoma cells. Genes Chromosomes and Cancer. 3(3). 221–230. 7 indexed citations
19.
Jones, Richard F., Maria Dêbiec‐Rychter, Kim Zukowski, & Ching Y. Wang. (1990). Activating missense mutations in Ha‐ras‐1 genes in a malignant subset of Bladder lesions induced by N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine or N‐[4‐(5‐nitro‐2‐furanyl)‐2‐thiazolyl]formamide. Molecular Carcinogenesis. 3(6). 393–402. 5 indexed citations
20.
Land, Susan, Kim Zukowski, Mei‐Sie Lee, et al.. (1989). Metabolism of aromatic amines: relationships of N-acetylation, O-acetylation, N,O-acetyltransfer and deacetylation in human liver and urinary bladder. Carcinogenesis. 10(4). 727–731. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026